In 2024, the U.S. Drug Enforcement Administration (DEA) indicated they plan to reclassify cannabis as a Schedule III drug. This rescheduling will acknowledge that cannabis has legit medical reasons and should help open the doorway to analysis on other potential therapy uses. Browse future Enterprise Insider tells the impressive tales https://thcdisposables.co.uk/